1. Home
  2. CLRO vs QNRX Comparison

CLRO vs QNRX Comparison

Compare CLRO & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

HOLD

Current Price

$5.26

Market Cap

14.4M

Sector

Technology

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$8.61

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLRO
QNRX
Founded
1983
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
14.5M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
CLRO
QNRX
Price
$5.26
$8.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.1K
27.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.59
N/A
52 Week Low
$0.29
$0.21
52 Week High
$15.42
$41.80

Technical Indicators

Market Signals
Indicator
CLRO
QNRX
Relative Strength Index (RSI) 45.21 48.09
Support Level $6.10 $7.13
Resistance Level $6.49 $10.44
Average True Range (ATR) 0.38 0.74
MACD -0.09 0.38
Stochastic Oscillator 0.00 60.76

Price Performance

Historical Comparison
CLRO
QNRX

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: